Bloomberg
Ventracor Ltd. (VCR AU), a heart implant maker, surged 29.5 cents, or 33 percent, to A$1.20. Its shares had their biggest rise in more than four years after the company said it finished enrolling patients in a clinical trial earlier than expected.